Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Walsh

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of Research of the National Institute of Standards and Technology|August 26, 2021
Jobs and Research-Related Outcomes from the NIST-ARRA Construction GrantsMichael D Walsh
Cancer Cytopathology|January 15, 2014
GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimensPaul W Shield, David J Papadimos, Michael D Walsh
Obstetrics and Gynecology|October 2, 2008
Lynch syndrome in women less than 50 years of age with endometrial cancerMichael D Walsh, Joanne Young, Amanda Spurdle, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 8, 2019
Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimensMelissa Vojtek, Michael D Walsh, David J Papadimos, et al.
Journal of Cytology|April 13, 2018
Gata3 Immunohistochemical Staining is A Useful Marker for Metastatic Breast Carcinoma in Fine Needle Aspiration SpecimensPaul W Shield, Stephen J Crouch, David J Papadimos, et al.
Future Oncology (London, England)|April 9, 2010
Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancerDaniel D Buchanan, Aedan Roberts, Michael D Walsh, et al.
The Australasian Journal of Dermatology|December 4, 2018
Clinico-pathological predictors of mismatch repair deficiency in sebaceous neoplasia: A large case series from a single Australian private pathology serviceMichael D Walsh, Harindra Jayasekara, Alvin Huang, et al.
Pathology|September 11, 2013
Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosisColin J R Stewart, Michael D Walsh, Charley A Budgeon, et al.
Gastroenterology|May 12, 2005
Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancerDaniel L Worthley, Michael D Walsh, Melissa Barker, et al.
Cancer Research|February 20, 2003
Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3Andrew P Barbour, Jennifer A Reeder, Michael D Walsh, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of Research of the National Institute of Standards and Technology|August 26, 2021
Jobs and Research-Related Outcomes from the NIST-ARRA Construction GrantsMichael D Walsh
Cancer Cytopathology|January 15, 2014
GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimensPaul W Shield, David J Papadimos, Michael D Walsh
Obstetrics and Gynecology|October 2, 2008
Lynch syndrome in women less than 50 years of age with endometrial cancerMichael D Walsh, Joanne Young, Amanda Spurdle, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|August 8, 2019
Claudin-4 immunohistochemistry is a useful pan-carcinoma marker for serous effusion specimensMelissa Vojtek, Michael D Walsh, David J Papadimos, et al.
Journal of Cytology|April 13, 2018
Gata3 Immunohistochemical Staining is A Useful Marker for Metastatic Breast Carcinoma in Fine Needle Aspiration SpecimensPaul W Shield, Stephen J Crouch, David J Papadimos, et al.
Future Oncology (London, England)|April 9, 2010
Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancerDaniel D Buchanan, Aedan Roberts, Michael D Walsh, et al.
The Australasian Journal of Dermatology|December 4, 2018
Clinico-pathological predictors of mismatch repair deficiency in sebaceous neoplasia: A large case series from a single Australian private pathology serviceMichael D Walsh, Harindra Jayasekara, Alvin Huang, et al.
Pathology|September 11, 2013
Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosisColin J R Stewart, Michael D Walsh, Charley A Budgeon, et al.
Gastroenterology|May 12, 2005
Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancerDaniel L Worthley, Michael D Walsh, Melissa Barker, et al.
Cancer Research|February 20, 2003
Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3Andrew P Barbour, Jennifer A Reeder, Michael D Walsh, et al.
Pageof 7